[Combination therapy with sulfonylurea and alpha-glucosidase inhibitor].
Iijima
T
T
Department of Internal Medicine, Urayasu Hospital, Juntendo University School of Medicine.
D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006442:Glycated Hemoglobin / Q000378:metabolism; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007294:Inositol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011498:Protein Precursors / Q000378:metabolism; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007294:Inositol; D011498:Protein Precursors; D013453:Sulfonylurea Compounds; C040839:pre-hemoglobin A, glycosylated; C102817:voglibose